Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas

NCT01140568 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

DRUG: nilotinib

Sponsor

David Piccioni, M.D., Ph.D

Collaborators

[object Object]